Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01888653 · ClinicalTrials.gov registry record · NA

Attention-Bias Modification Treatment for PTSD

A NA study, sponsored by Research Foundation for Mental Hygiene.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT01888653 is a NA study that has completed, run by Research Foundation for Mental Hygiene. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01888653, a NA study, has completed, sponsored by Research Foundation for Mental Hygiene.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

Emerging research implicates biased attention to threat in the pathophysiology of anxiety disorders. Recent findings demonstrate significant associations between attention bias and stress vulnerability. This work has motivated the development of a novel therapy, attention-bias-modification (ABM) treatment . ABM is designed to implicitly modify patients' biased threat attendance via computerized training protocols. Emerging evidence indicates that ABM is effective in modifying threat-related attention biases and in ameliorating anxiety symptoms. However, it is unclear whether ABM is efficacious for posttraumatic stress disorder (PTSD). The present pilot study is a double blind trial that seeks to examine feasibility, acceptability, safety, efficacy, and risk/benefit ratio of ABM in individuals with PTSD. In addition this pilot study seeks to identify specific genes associated with anxiety disorders and to examine whether these can predict the success of the ABM.

Interventions

  • BEHAVIORAL Attention Bias Modification (ABM)
  • BEHAVIORAL Attention control training (ACT)

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2013-05
Est. Completion 2018-04-02
Phase NA

What the Registry Record Tells You About NCT01888653

The ClinicalTrials.gov registry entry for NCT01888653 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Research Foundation for Mental Hygiene, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Attention Bias Modification (ABM) is the first listed.

NCT01888653 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01888653 about?

NCT01888653 is a clinical study titled "Attention-Bias Modification Treatment for PTSD". Emerging research implicates biased attention to threat in the pathophysiology of anxiety disorders. Recent findings demonstrate significant associations between attention bias and stress vulnerability. This work has motivated the development of a novel therapy, attention-bias-modification (ABM) tre...

What is the current status of trial NCT01888653?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2013-05. Estimated completion is 2018-04-02.

What interventions are being tested in trial NCT01888653?

The interventions under investigation include: Attention Bias Modification (ABM) (BEHAVIORAL), Attention control training (ACT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01888653?

This trial is sponsored by Research Foundation for Mental Hygiene, which has 27 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.